Literature DB >> 17687557

High expression of CD40 on skin fibroblasts from patients with systemic sclerosis.

Jae-Bum Jun, Tae-Hwan Kim, Young-In Na, Dae-Hyun Yoo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17687557     DOI： 10.1007/s00296-007-0393-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  10 in total

1.  Fibroblasts as sentinel cells: role of the CDcd40-CDcd40 ligand system in fibroblast activation and lung inflammation and fibrosis.

Authors:  J Kaufman; B A Graf; E C Leung; S J Pollock; L Koumas; S Y Reddy; T M Blieden; T J Smith; R P Phipps
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

Review 2.  Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment.

Authors:  P J Sime; K M O'Reilly
Journal:  Clin Immunol       Date:  2001-06       Impact factor: 3.969

3.  Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.

Authors:  R Sgonc; M S Gruschwitz; H Dietrich; H Recheis; M E Gershwin; G Wick
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

5.  Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.

Authors:  X Shi-Wen; C P Denton; M R Dashwood; A M Holmes; G Bou-Gharios; J D Pearson; C M Black; D J Abraham
Journal:  J Invest Dermatol       Date:  2001-03       Impact factor: 8.551

6.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

7.  Endothelin-1 regulation of intercellular adhesion molecule-1 expression in normal and sclerodermal fibroblasts.

Authors:  S W Xu; C P Denton; M R Dashwood; D J Abraham; C M Black
Journal:  J Cardiovasc Pharmacol       Date:  1998       Impact factor: 3.105

8.  Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.

Authors:  C Mavalia; C Scaletti; P Romagnani; A M Carossino; A Pignone; L Emmi; C Pupilli; G Pizzolo; E Maggi; S Romagnani
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

9.  Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts.

Authors:  Chikako Fukasawa; Yasushi Kawaguchi; Masayoshi Harigai; Tomoko Sugiura; Kae Takagi; Manabu Kawamoto; Masako Hara; Naoyuki Kamatani
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

10.  Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?

Authors:  R Vancheeswaran; T Magoulas; G Efrat; C Wheeler-Jones; I Olsen; R Penny; C M Black
Journal:  J Rheumatol       Date:  1994-10       Impact factor: 4.666
  10 in total
  1 in total

Review 1.  Targeting Costimulatory Pathways in Systemic Sclerosis.

Authors:  Gonçalo Boleto; Yannick Allanore; Jérôme Avouac
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.